Abstract: An ultrasonic diagnostic imaging system including a main body housing imaging electronics and a control panel coupled to the imaging electronics comprising: a flat panel display electrically coupled to the imaging electronics; an articulating arm assembly to which the flat panel display is connected for adjusting the viewing position of the flat panel display, the articulating arm assembly including a first lower arm movably mounted to the main body or to the control panel and a second upper arm movably connected to the first lower arm and to the flat panel display, wherein at least one of the arms includes a 4-bar linkage; and a locking mechanism which acts to restrict motion of the articulating arm assembly, characterised in that the locking mechanism comprises a protrusion and a lever having a corresponding seat for engagement of the protrusion, the lever being hinged on one of the two arms to pivot from a rest position to a lock position, the protrusion being correspondingly located on the other arm or

Abstract: Disclosed are new processes for the preparation of known polymorphs of ivabradine HCl, such processes being characterized by robust protocols suitable for industrial production.

Abstract: Disclosed are new intermediates for the synthesis of Linagliptin and of its salts and a process for its preparation involving said intermediates.

Abstract: Disclosed is a process for the preparation of Raltegravir and pharmaceutically acceptable salts thereof.

Abstract: Disclosed are new intermediates for the synthesis of Linagliptin and of its salts and a process for its preparation involving said intermediates.

Abstract: Disclosed is a process for the preparation of Raltegravir and pharmaceutically acceptable salts thereof.

Abstract: Capsules or microcapsules comprising: a) a nucleus containing seminal material or the spermatozoa of animal species chosen from the group consisting of equids, buffalo, ovicaprids, canids, felids, lagomorphs, laboratory animal species chosen from mice and rats, and possibly man, b) a membrane of a bivalent or trivalent metal alginate.

Abstract: The present invention relates to gastroresistant and enterosoluble microparticulate systems for the encapsulation of biologically active substances selected from: flavonoids, vitamins, antioxidants, immunostimulants, starchy and non-starchy polysaccharides, probiotics, prebiotics, intestinal trophism regulators, oligoelements, enzymes and bioactive peptides. Such microparticulate systems allow the administration of the aforementioned nutraceutic substances to animals such as porcines, bovines, caprines, ovines, equids, canids, felines, camelids, lagomorphs, rodents, fowl, and other mammals, including humans, fish and crustaceans, increasing the bioavailability.

Abstract: A process for encapsulating and immobilising mammalian stem cells, ovarian follicular cells, gametes, ovarian follicles or mammalian embryos which are able to auto-organise into three-dimensional structures in vitro, and express biological functions in a manner similar to that which is observed in the organism in vivo is described. The capsules are constituted by: a nucleus containing stem cells, ovarian follicular cells, gametes ovarian follicles or mammalian embryos and/or a biocompatible and/or biodegradable polymer; a semi-permeable membrane constituted by a divalent or trivalent metal ion salt of alginic acid, optionally cross-linked on the inner and/or outer surface and/or on both surfaces, optionally vehicularising a second or more cellular species.